An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

Inclusion Criteria:

1. Documented active diagnosis of colorectal cancer.

2. Cachexia defined by Fearon criteria of weight loss.

3. Signed informed consent.

Exclusion Criteria:

1. Current active reversible causes of decreased food intake.

2. Receiving tube feedings or parenteral nutrition at the time of Screening orRandomization.

3. Have cachexia caused by other reasons.